NDC product
Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%
NDC 21922-052 · Encube Ethicals, Inc.
Key facts
| Product NDC | 21922-052 |
|---|---|
| Proprietary name | Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5% |
| Nonproprietary name | Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5% |
| Substances | ADAPALENE, BENZOYL PEROXIDE |
| Dosage form | GEL |
| Route | TOPICAL |
| Labeler | Encube Ethicals, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA206164 |
| Pharmacologic classes | Retinoid [EPC], Retinoids [CS] |
| Marketing start | Aug 14, 2023 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: